The non-recurrent translocation group tends to show complex genomic changes including gains/amplifications and deletions in multiple chromosomal regions,[3,6] or activating mutations (e.g. KIT and PDGFRA) in gastrointestinal stromal tumors (GIST). This evidence concerns the gene PDGFRA and gastrointestinal stromal tumor.